An Exploratory Study of the Safety and Efficacy of BOTOX for the Treatment of Premature Ejaculation
Phase of Trial: Phase II
Latest Information Update: 22 Sep 2017
At a glance
- Drugs Botulinum toxin A (Primary)
- Indications Premature ejaculation
- Focus Therapeutic Use
- Sponsors Allergan
- 18 Sep 2017 Status changed from recruiting to discontinued.
- 03 Oct 2016 Planned End Date changed from 1 Dec 2016 to 1 Dec 2017.
- 03 Oct 2016 Planned primary completion date changed from 1 Oct 2016 to 1 Oct 2017.